Sex (biological factors) and gender (socio-culturally constructed norms) affect almost every aspect of cardiovascular disease. For women with heart failure, this confluence of sex and gender results in unique and significant differences from men with the same condition, from clinical presentation and management to clinical outcomes.
The American Transplant Congress (ATC) is the annual international meeting for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS). Heart transplant physician researchers from the Center for Advanced Heart and Lung Disease at Baylor University Medical Center at Dallas (Baylor Dallas) played a prominent role in ATC 2024, which was held in early June in Philadelphia, PA.
The Aurora Extravascular ICD system is designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest, while avoiding certain risks of traditional, transvenous ICDs because its lead is placed outside the heart and veins, under the breastbone using a minimally invasive approach.
For more than three years, the cardiology team at Baylor Scott & White Heart and Vascular Hospital – Fort Worth has been an active enrollment site for the Amplatzer Amulet LAAO vs. NOAC clinical trial (CATALYST).
Transthyretin, or ATTR, amyloidosis is a rare disease that, if left untreated, can be devasting and fatal to the patient. Fortunately, in the past decade, there have been advancements in specialized therapies targeting this disease that can improve both quality of life and survival. The Advanced Heart and Lung Disease Center at Baylor Scott & White All Saints Medical Center – Fort Worth is one of the first heart centers in Tarrant County to use Vutisiran (administered under the name of Amvuttra), a small inhibiting RNA silencer that targets the transthyretin protein transcription pathway, to treat the condition. Salman Gohar, MD, FACC, medical director of advanced heart failure and mechanical circulatory support at Baylor Scott & White – Fort Worth and Baylor Scott & White Heart and Vascular Hospital – Fort Worth, is on a mission to help physicians identify this disease early, approaching diagnosis through a new lens.
